Mirum Pharmaceuticals
MIRM
MIRM
116 hedge funds and large institutions have $833M invested in Mirum Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 40 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 103 → 116 (+13)
0.95% more ownership
Funds ownership: 90.4% → 91.36% (+0.95%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Holders
116
Holding in Top 10
6
Calls
$10.3M
Puts
$84K
Top Buyers
| 1 | +$19.3M | |
| 2 | +$14.4M | |
| 3 | +$8.59M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
+$6.22M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$5.81M |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$10.3M | |
| 3 | -$3.41M | |
| 4 |
Citigroup
New York
|
-$2.36M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.12M |